{"symbol": "RGEN", "companyName": "Repligen Corporation", "exchange": "Nasdaq Global Select", "industry": "Biotechnology", "website": "http://www.repligen.com", "description": "Repligen Corp is a bioprocessing company developing, producing and commercializing biologic drugs. The company offers its products to life science companies, global biopharmaceutical companies, and contract manufacturers worldwide.", "CEO": "Tony J. Hunt", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}